Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 149

Similar articles for PubMed (Select 23435316)

1.

Power spectral analysis of heart rate variability in cynomolgus monkeys in safety pharmacology studies: comparative study with beagle dogs.

Champeroux P, Martel E, Jude S, Laigot C, Laveissière A, Weyn-Marotte AA, Fowler JS, Maurin A, Richard S, Babuty D.

J Pharmacol Toxicol Methods. 2013 Jul-Aug;68(1):166-74. doi: 10.1016/j.vascn.2013.02.005. Epub 2013 Feb 19.

PMID:
23435316
2.

Calculation of QT shift in non clinical safety pharmacology studies.

Champeroux P, Martel E, Fowler JS, Maurin A, Sola ML, Jude S, Elamrani F, Weyn AA, Laveissiere A, Lala P, Richard S.

J Pharmacol Toxicol Methods. 2009 Mar-Apr;59(2):73-85. doi: 10.1016/j.vascn.2008.11.001. Epub 2008 Dec 10.

PMID:
19135537
3.

Comparison of freely-moving telemetry Chinese Miniature Experiment Pigs (CMEPs) to beagle dogs in cardiovascular safety pharmacology studies.

Yuan H, Zhao J, Guo J, Wu R, He L, Cui Y, Feng M, Zhang T, Hou M, Guo Q, Zhang L, Jia L, Huang C, Ye L, Peng S.

J Pharmacol Toxicol Methods. 2014 Jul-Aug;70(1):19-28. doi: 10.1016/j.vascn.2014.03.172. Epub 2014 Apr 8.

PMID:
24721420
4.

Identification of low and high frequency ranges for heart rate variability and blood pressure variability analyses using pharmacological autonomic blockade with atropine and propranolol in swine.

Poletto R, Janczak AM, Marchant-Forde RM, Marchant-Forde JN, Matthews DL, Dowell CA, Hogan DF, Freeman LJ, Lay DC Jr.

Physiol Behav. 2011 May 3;103(2):188-96. doi: 10.1016/j.physbeh.2011.01.019. Epub 2011 Jan 28.

PMID:
21281655
5.

A cardiovascular monitoring system in conscious cynomolgus monkeys for regulatory safety pharmacology. Part 1: Non-pharmacological validation.

Authier S, Tanguay JF, Gauvin D, Di Fruscia R, Fournier S, Chaurand F, Troncy E.

J Pharmacol Toxicol Methods. 2007 Sep-Oct;56(2):115-21. Epub 2007 May 24.

PMID:
17587601
6.

The cardiovascular and pharmacokinetic profile of dofetilide in conscious telemetered beagle dogs and cynomolgus monkeys.

Haushalter TM, Friedrichs GS, Reynolds DL, Barecki-Roach M, Pastino G, Hayes R, Bass AS.

Br J Pharmacol. 2008 Aug;154(7):1457-64. doi: 10.1038/bjp.2008.275. Epub 2008 Jul 7.

7.

Assessment of two external telemetry systems (PhysioJacket and JET) in beagle dogs with telemetry implants.

Chui RW, Fosdick A, Conner R, Jiang J, Bruenner BA, Vargas HM.

J Pharmacol Toxicol Methods. 2009 Jul-Aug;60(1):58-68. doi: 10.1016/j.vascn.2009.04.196. Epub 2009 May 5.

PMID:
19426820
8.

The value added by measuring myocardial contractility 'in vivo' in safety pharmacological profiling of drug candidates.

Markert M, Klumpp A, Trautmann T, Mayer K, Stubhan M, Guth B.

J Pharmacol Toxicol Methods. 2007 Sep-Oct;56(2):203-11. Epub 2007 May 24.

PMID:
17583538
9.

Intravenous solid tip ECG lead placement in telemetry implanted dogs: Part 2: High quality telemetry signals yield high sensitivity to drug-induced changes.

Mitchell AZ, Bills AJ, Wittwer GT, Foley CM, Kremer JJ, Chen H, Osinski MA.

J Pharmacol Toxicol Methods. 2013 Jul-Aug;68(1):62-73. doi: 10.1016/j.vascn.2013.04.006. Epub 2013 Apr 29.

PMID:
23639348
10.

A pharmacokinetic-pharmacodynamic model for cardiovascular safety assessment of R1551.

Fleury A, Lavé T, Jonsson F, Schmitt M, Hirkaler G, Polonchuk L, Breidenbach A.

J Pharmacol Toxicol Methods. 2011 Jan-Feb;63(1):123-33. doi: 10.1016/j.vascn.2010.08.003. Epub 2010 Aug 21.

PMID:
20732434
11.

Different species require different correction factors for the QT interval.

Soloviev MV, Hamlin RL, Barrett RM, Chengelis CP, Schaefer GJ.

Cardiovasc Toxicol. 2006;6(2):145-57.

PMID:
17303921
12.

Translational PK/PD modeling for cardiovascular safety assessment of drug candidates: Methods and examples in drug development.

Caruso A, Frances N, Meille C, Greiter-Wilke A, Hillebrecht A, Lavé T.

J Pharmacol Toxicol Methods. 2014 Jul-Aug;70(1):73-85. doi: 10.1016/j.vascn.2014.05.004. Epub 2014 May 28.

PMID:
24879942
13.
14.

A multi-site comparison of in vivo safety pharmacology studies conducted to support ICH S7A & B regulatory submissions.

Ewart L, Milne A, Adkins D, Benjamin A, Bialecki R, Chen Y, Ericsson AC, Gardner S, Grant C, Lengel D, Lindgren S, Lowing S, Marks L, Moors J, Oldman K, Pietras M, Prior H, Punton J, Redfern WS, Salmond R, Skinner M, Some M, Stanton A, Swedberg M, Finch J, Valentin JP.

J Pharmacol Toxicol Methods. 2013 Jul-Aug;68(1):30-43. doi: 10.1016/j.vascn.2013.04.008. Epub 2013 May 9.

PMID:
23665080
16.

Age-related differences of QT interval and autonomic nervous system activity in female cynomolgus monkeys.

Ishizaka T, Yoshimatsu Y, Ozawa M, Kimotsuki T, Takasaki W, Manabe S, Yasuda M.

J Pharmacol Toxicol Methods. 2009 Nov-Dec;60(3):288-95. doi: 10.1016/j.vascn.2009.06.003. Epub 2009 Jul 6.

PMID:
19586616
17.

Power spectral analysis of heart rate variability as a new method for assessing autonomic activity in the rat.

Kuwahara M, Yayou K, Ishii K, Hashimoto S, Tsubone H, Sugano S.

J Electrocardiol. 1994 Oct;27(4):333-7.

PMID:
7815012
18.

A cardiovascular monitoring system used in conscious cynomolgus monkeys for regulatory safety pharmacology. Part 2: Pharmacological validation.

Authier S, Tanguay JF, Gauvin D, Fruscia RD, Troncy E.

J Pharmacol Toxicol Methods. 2007 Sep-Oct;56(2):122-30. Epub 2007 May 24.

PMID:
17587605
19.

Dose-response effects of sotalol on cardiovascular function in conscious, freely moving cynomolgus monkeys.

Lynch JJ 3rd, Wilson AW, Hernandez LE, Nelson RA, Marsh KC, Cox BF, Mittelstadt SW.

Br J Pharmacol. 2008 Aug;154(7):1439-45. doi: 10.1038/bjp.2008.206. Epub 2008 Jun 2.

20.

Analysis of the nonclinical telemetered ECG: impact of logging rate and RR bin width in the dog and cynomolgus monkey.

Holzgrefe HH, Cavero I, Gleason CR.

J Pharmacol Toxicol Methods. 2007 Jul-Aug;56(1):34-42. Epub 2006 Dec 20.

PMID:
17258913
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk